Acute Encephalitis During a SARS-CoV-2 Infection: A Case Report
Yousfi Samah, Ansam Milhi, Sanae Elhasnaoui, Yassine Mebrouk

TL;DR
A 49-year-old woman with severe COVID-19 developed acute encephalitis and showed improvement after corticosteroid treatment.
Contribution
This case report highlights acute encephalitis as a neurological complication of SARS-CoV-2 infection.
Findings
A 49-year-old female with afebrile impaired consciousness was diagnosed with acute encephalitis and severe COVID-19.
Treatment with corticosteroids led to clinical and radiological improvement in the patient.
Abstract
It was in December 2019 that the coronavirus causing COVID-19 was first detected in Wuhan, China. Although the primary clinical presentation is respiratory disease, an increasing number of reports worldwide have noted various neurological manifestations, such as acute encephalitis. We present a case of a 49-year-old female admitted with afebrile impaired consciousness, diagnosed with acute encephalitis and a severe infection of COVID-19. Clinical and radiological improvement was observed following treatment with corticosteroids.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsLong-Term Effects of COVID-19 · Infectious Encephalopathies and Encephalitis · COVID-19 Clinical Research Studies
